Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Closing Treatment Gaps for Polyendocrine Metabolic Ovarian Syndrome in India.

Created on 30 Sep 2026

Authors

Bharath Thampi

Published in

Journal of medical Internet research. Volume 28. Pages e112910. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Polycystic ovarian syndrome, also known by the newly proposed term polyendocrine metabolic ovarian syndrome (PMOS), is an understudied and underfunded condition, despite its health burden and the urgent need for more effective treatment. In this News and Perspectives article, JMIR Correspondent Bharath Thampi reports on the factors affecting PMOS treatment in India-especially rural regions-and on a new digital twin treatment initiative.

PMID:
42809745
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement